Angiolab, Inc. (XKON:251280)
South Korea
· Delayed Price · Currency is KRW
2,365.00
-25.00 (-1.05%)
At close: Mar 9, 2026
Angiolab Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2015 | FY 2014 |
| Mar '26 Mar 6, 2026 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
| Debt / Equity Ratio | - | - | 0.13 |
| Net Debt / Equity Ratio | -0.70 | -0.70 | -0.59 |
| Net Debt / EBITDA Ratio | 5.14 | 5.14 | 12.38 |
| Net Debt / FCF Ratio | 23.60 | 23.60 | 15.23 |
| Asset Turnover | 0.13 | 0.13 | - |
| Inventory Turnover | 1.30 | 1.30 | - |
| Quick Ratio | 6.05 | 6.05 | 4.79 |
| Current Ratio | 6.73 | 6.73 | 5.23 |
| Return on Equity (ROE) | -28.58% | -28.58% | - |
| Return on Assets (ROA) | -8.55% | -8.55% | - |
| Return on Capital Employed (ROCE) | -18.00% | -18.00% | -7.00% |
| Buyback Yield / Dilution | - | 0.09% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.